Our finding of significantly decreased CD4/CD8 ratio is mismatched with (Gessl et al. 1995) in the HT group, and they also reported a significantly increased ratio in Graves’ disease, which is also contrary to our finding. This evidence concerns the gene CD8A and Graves disease.